MX9800308A - Nuevos inhibidores de agregacion de plaquetas. - Google Patents
Nuevos inhibidores de agregacion de plaquetas.Info
- Publication number
- MX9800308A MX9800308A MX9800308A MX9800308A MX9800308A MX 9800308 A MX9800308 A MX 9800308A MX 9800308 A MX9800308 A MX 9800308A MX 9800308 A MX9800308 A MX 9800308A MX 9800308 A MX9800308 A MX 9800308A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- alkyl
- platelet aggregation
- cooh
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describen compuestos de la formula (I), en donde B es 0 o CH2; X se selecciona de NR1R2, SR1, y alquilo C1-C7; Y se selecciona de SR1NR1R2, y alquilo C1-C7; R1 y R2 son cada uno seleccionados independientemente de H, o alquilo C1-C7 opcionalmente sustituido sobre o dentro de la cadena del alquilo por uno más de O, S, N o halogeno, R3 y R4 son ambos h, a R3 y R4 juntos forman un enlace; A es COOH, C(O)NH(CH2)pCOOH, C(O)N[(CH2)qCOOH]2; C(O)NHCH(COOH)(CH2)rCOOH,o 5-tetrazolilo, en donde p, q y r son cada uno e independientemente 1, 2 o 3; así como las sales farmacéuticamente aceptables y promedicamentos de los mismos, composiciones farmacéuticas que comprenden los compuestos novedosos y el uso de los compuestos en terapia. También dentro del alcance de la invencion están intermediarios novedosos para los compuestos novedosos. Los compuestos novedosos son en particular utiles en la prevencion de agregacion de plaquetas.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9514074.5A GB9514074D0 (en) | 1995-07-11 | 1995-07-11 | Compounds |
GB9514074.5 | 1995-07-11 | ||
GB9520311.3 | 1995-10-05 | ||
GBGB9520311.3A GB9520311D0 (en) | 1995-10-05 | 1995-10-05 | Compounds |
GBGB9522837.5A GB9522837D0 (en) | 1995-11-08 | 1995-11-08 | Compounds |
GB9522837.5 | 1995-11-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9800308A true MX9800308A (es) | 1998-09-30 |
MXPA98000308A MXPA98000308A (es) | 1998-11-16 |
Family
ID=
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY116542A (en) | New inhibitors of platelet aggregation. | |
MY132073A (en) | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents | |
GR3032311T3 (en) | Stilbene derivatives and pharmaceutical compositions containing them | |
ATE203515T1 (de) | Meta-substituierte phenylsulphonamidderivate | |
AP2002002637A0 (en) | Novel piperazine | |
IL133623A0 (en) | Antithrombotic agents | |
IL133627A0 (en) | Antithrombotic agents | |
IT1254373B (it) | Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico. | |
DE69415445D1 (de) | Zytotoxische Stilben-Derivate und diese enthaltende pharmazeutische Zusammensetzungen | |
NO913750D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
MY133473A (en) | Haterocyclic glycyl beta-alanine derivatives. | |
MY113733A (en) | Salts of an anti-migraine indole derivative | |
DK0889875T3 (da) | Cycloproylalkansyrederivater | |
SG45336A1 (en) | A pharmaceutical composition for angiotens ii-mediated diseases | |
ATE170845T1 (de) | Plättchenaggregationsinhibitoren | |
IL136100A0 (en) | Biphenylamidine derivatives, prodrugs thereof and pharmaceutical compositions containing the same | |
DK0659193T3 (da) | Blodpladeaggregationsinhibitorer | |
EP0604354A3 (en) | Antidepressant and anti-parkinsonian compounds. | |
EP0351385A3 (en) | New amidino and guanidino derivatives | |
IL115747A0 (en) | Polyanionic benzylglycosides of benzene triacid amides and pharmaceutical compositions containing them | |
DE602004007181D1 (de) | 2,4,6-tris(4'aminobenzaldineopentylmalonat)-s-triazin, dieser enthaltenden Sonnenschutzzusammensetzungen und dessen Verwendungen | |
DE69330601T2 (de) | Serotoninergische ergolin derivate | |
HUP0301553A2 (hu) | Gyógyászati készítmények és alkalmazásuk neurológiai rendellenességek kezelésére | |
DE3662264D1 (en) | Anticonvulsant agents | |
DE68909025D1 (de) | Mittel zur Verhinderung von Zahnbelagbildung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
PD | Change of proprietorship |
Owner name: ASTRAZENECA AB |
|
MM | Annulment or lapse due to non-payment of fees |